AMICUS THERAPEUTICS,

FOLD
Delayed Quote. Delayed  - 10/26 04:00:00 pm
18.75USD +1.46%
Prev.18.4800
Open18.2300
High18.8765
Low17.2000
Volume1 772 315
Latest news
3d ago
5d ago
5d ago
10/13
Chart AMICUS THERAPEUTICS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance20,620,624,2
Spread/Res.-8,8%-8,8%-22%
Spread/Supp.28%28%45%
Support14,614,612,9
Financials
Sales 2020 257 M - -
Net income 2020 -240 M - -
Net cash 2020 54,1 M - -
P/E ratio 2020 -19,9x
Yield 2020 -
Capitalization 4 852 M 4 852 M -
EV / Sales 2020 18,7x
EV / Sales 2021 14,0x
Nbr of Employees 584
Free-Float 89,6%
Company
Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The Company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio....

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2020-11-05 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 10
Average target price 20,10 $
Last Close Price 18,75 $
Spread / Highest target 65,3%
Spread / Average Target 7,20%
Spread / Lowest Target -36,0%